First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2009-04-02 11:03:00Open Document File Size: 78,04 KBShare Result on FacebookCityRockville / Montville / /CompanyS-034 Bayer Pharmaceuticals Corporation / Bayer Pharmaceuticals Corporation / /EventFDA Phase / /FacilityNational Library of Medicine / /IndustryTermsupplemental new drug applications / shipped product / printing / drug product / supplemental applications / healthcare / /MedicalConditionTendinopathy / severe tendon disorders / tendinitis / severe tendon disorder / tendonitis / rheumatoid arthritis / pain / tendon disorders / serious tendon disorders / renal failure / inflammation / /MedicalTreatmentlung transplants / /MoviePage 3 4 / /OrganizationFood and Drug Administration / Special Pathogen and Transplant Products Office / Antimicrobial Products Center for Drug Evaluation and Research Enclosure / DEPARTMENT OF HEALTH / Division of Special Pathogen / /PersonRenata Albrecht / Janet Herrington / Kristen Miller / / /PositionDirector / physician / Deputy Director / Regulatory Affairs P.O. Box / Safety Regulatory Project Manager / M.D. Director / /Productmoxifloxacin hydrochloride / AVELOX / NaCl injection / S-034 / NDA / S-040 / /ProvinceOrStateNew Jersey / Maryland / /URLhttp /SocialTag |